y 27632 has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominguez-Meijide, A; Guerra, MJ; Labandeira-Garcia, JL; Lanciego, JL; Rodriguez-Perez, AI | 1 |
| Borrajo, A; Guerra, MJ; Labandeira-Garcia, JL; Rodriguez-Perez, AI; Villar-Cheda, B | 1 |
2 other study(ies) available for y 27632 and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Ovariectomy; Pyridines; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Tetrazoles; Tyrosine 3-Monooxygenase | 2013 |
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.
Topics: Amides; Animals; Axons; Cell Culture Techniques; Cell Death; Cell Line, Tumor; Cells, Cultured; Dopaminergic Neurons; Mesencephalon; Microglia; MPTP Poisoning; Neurites; Neuroprotective Agents; Pyridines; Rats; rho-Associated Kinases | 2014 |